ARC

ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System

Retrieved on: 
Monday, March 11, 2024

This acceptance follows ONWARD Medical’s announcement last week that its investigational ARC-BCI System was awarded FDA Breakthrough Device Designation (BDD), a requirement for TAP consideration.

Key Points: 
  • This acceptance follows ONWARD Medical’s announcement last week that its investigational ARC-BCI System was awarded FDA Breakthrough Device Designation (BDD), a requirement for TAP consideration.
  • ONWARD Medical is only the second BCI company to be accepted into the program.
  • TAP provides ONWARD Medical with early and frequent strategic engagement from the FDA, patients, providers, and payers to facilitate more rapid development and widespread patient access to safe, effective, high-quality medical devices of public health importance.
  • “We are honored to be one of the first BCI companies included in this important program, which allows for the fastest FDA review times of new medical technology,” said ONWARD Medical CEO Dave Marver.

Canada nowhere near gender parity

Retrieved on: 
Monday, March 4, 2024

While The Prosperity Project’s Annual Report Card on Gender Equity and Leadership (ARC) identifies some positive movement toward gender parity for Canadian women in general, it finds a continued dearth of representation for women in corporate leadership positions.

Key Points: 
  • While The Prosperity Project’s Annual Report Card on Gender Equity and Leadership (ARC) identifies some positive movement toward gender parity for Canadian women in general, it finds a continued dearth of representation for women in corporate leadership positions.
  • Highlights of the 2024 Annual Report Card:
    Canada is nowhere near achieving gender parity.
  • No industry can claim victory in the quest for gender parity.
  • Private companies are catching up to crown corporations in achieving gender parity.

ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA

Retrieved on: 
Thursday, February 29, 2024

This is the tenth FDA BDD awarded to ONWARD Medical.

Key Points: 
  • This is the tenth FDA BDD awarded to ONWARD Medical.
  • The designation is reserved for novel, cutting-edge therapies addressing an unmet need and provides many potential regulatory and reimbursement advantages.
  • This latest award gives ONWARD Medical priority FDA review, the opportunity to interact with FDA experts throughout the pre-market regulatory review phase, and the potential to seek additional reimbursement for its ARC-BCI System.
  • “Brain-computer interface technology unlocks the transformative potential to enhance ARC-IM with thought-driven control of movement after paralysis,” said ONWARD Medical CEO Dave Marver.

City of Richmond in California Selects Beam Global EV ARC™ Product to Power Car Share Program in Underserved Community

Retrieved on: 
Thursday, February 29, 2024

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, announced that the City of Richmond in California has selected EV ARC™ sustainable electric vehicle (EV) charging to power their car share program, which offers flexible transportation benefitting underserved communities. EV ARC™ systems are purchased through the California Department of General Services (DGS) Contract #1-22-61-16, which serves to simplify the government procurement process and make select solutions available statewide at the best negotiated pricing.

Key Points: 
  • Because EV ARC™ systems generate and store their own clean electricity, there is no utility bill to pay, making them an ideal solution for car share programs especially in underserved communities.
  • This initiative is part of the Clean Mobility Options Voucher Pilot Project (CMO) program, made possible by Richmond Community Foundation, Miocar and funding from the California Air Resources Board (CARB).
  • The program includes electric vehicles and sustainable charging to provide underserved community members access to clean transportation.
  • “We’ve seen an increase in car share programs across the country and they can be especially life-changing in underserved communities,” said Desmond Wheatley, CEO of Beam Global.

Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases

Retrieved on: 
Thursday, February 29, 2024

PETAH TIKVA, Israel, Feb. 29, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, and Beilinson Hospital, a leading Israeli hospital and part of Rabin Medical Center, owned and operated by Israel’s largest healthcare organization, Clalit Health Services, today announced their collaboration to conduct a clinical study evaluating the Nanox.ARC 3D imaging system in a clinical outpatient setting at Beilinson Hospital. The study will specifically assess the diagnostic capabilities of the Nanox.ARC’s tomographic imaging system compared with conventional two-dimensional radiography for detection of lung and chest disease in adults. Such a study may help determine the clinical utility of the additional information provided by the 3D tomographic imaging, potentially preventing the need for more advanced imaging and exposure to additional radiation.

Key Points: 
  • The study will specifically assess the diagnostic capabilities of the Nanox.ARC’s tomographic imaging system compared with conventional two-dimensional radiography for detection of lung and chest disease in adults.
  • The study is being led by Professor Eli Atar, M.D., FSIR, Director of the Department of Imaging, and Dr. Ahuva Grubstein, M.D., Department of Diagnostic Radiology, both at Beilinson Hospital.
  • This study evaluating the Nanox.ARC is an addition to the existing collaboration between Nanox AI and Clalit, and the second study conducted with Beilinson Hospital.
  • “This technology shows promise to expand clinicians’ capabilities for more precise readings and earlier detection across a range of pulmonary conditions.

GENERAL MOTORS COMPANY (NYSE: GM) INVESTIGATION ALERT: Bernstein Liebhard is Investigating General Motors Company

Retrieved on: 
Monday, February 26, 2024

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential mismanagement at General Motors Company (“General Motors” or the “Company”) (NYSE: GM) in connection with the Company’s autonomous vehicle unit, Cruise, and the Company’s continued use of airbag inflators manufactured by ARC Automotive, Inc. in millions of its vehicles.

Key Points: 
  • If so, please visit General Motors Company Shareholder Investigation or contact paralegal Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential mismanagement at General Motors Company (“General Motors” or the “Company”) (NYSE: GM) in connection with the Company’s autonomous vehicle unit, Cruise, and the Company’s continued use of airbag inflators manufactured by ARC Automotive, Inc. in millions of its vehicles.
  • If you hold General Motors stock and would like to discuss your legal rights and options, please visit General Motors Company Shareholder Investigation or contact paralegal Peter Allocco at (212) 951-2030 or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

GENERAL MOTORS COMPANY (NYSE: GM) INVESTIGATION ALERT: Bernstein Liebhard is Investigating General Motors Company

Retrieved on: 
Tuesday, February 20, 2024

NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential mismanagement at General Motors Company (“General Motors” or the “Company”) (NYSE: GM) in connection with the Company’s autonomous vehicle unit, Cruise, and the Company’s continued use of airbag inflators manufactured by ARC Automotive, Inc. in millions of its vehicles.

Key Points: 
  • If so, please visit General Motors Company Shareholder Investigation or contact paralegal Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • NEW YORK, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential mismanagement at General Motors Company (“General Motors” or the “Company”) (NYSE: GM) in connection with the Company’s autonomous vehicle unit, Cruise, and the Company’s continued use of airbag inflators manufactured by ARC Automotive, Inc. in millions of its vehicles.
  • If you hold General Motors stock and would like to discuss your legal rights and options, please visit General Motors Company Shareholder Investigation or contact paralegal Peter Allocco at (212) 951-2030 or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

COPE Health Solutions and the Analytics for Risk Contracting Platform Collaborate with Findhelp to Bring Market Leading HRSN Solutions to New York

Retrieved on: 
Friday, March 8, 2024

The Findhelp and ARC solution will enable SCNs to improve quality and total cost of care outcomes by closing health equity gaps and improving care plan adherence.

Key Points: 
  • The Findhelp and ARC solution will enable SCNs to improve quality and total cost of care outcomes by closing health equity gaps and improving care plan adherence.
  • Findhelp’s platform offers unrivaled capabilities for completing Health Related Social Needs (HRSN) screening, matching the needs of the population to the right CBO solution, and facilitating closed-loop referrals to CBOs.
  • The platform also allows providers and CBOs to handle case management, claims management, and payment for HRSN services all in one place.
  • ARC’s analytics help to understand specific funding initiatives to report and compare outcomes and ROI across HRSN services and CBOs.

ARC Fertility Teams Up with Leapfrog for High-Value Family-Forming Benefits Webinar, Invites Self Insurance Stakeholders to Attend

Retrieved on: 
Tuesday, March 5, 2024

In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.

Key Points: 
  • In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.
  • David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility, and Eliza Chin, MD, MPH, Executive Director, American Medical Women's Association (AMWA), will lead the discussion.
  • ARC Fertility is set to guide CEOs, CFOs and corporate human resources (CHRs) through the intricate landscape of family-forming benefits.
  • Drawing from our experience, we will explore the challenges employers face and the benefits of a flexible and affordable family-forming benefits solution.

ARC Ltd. and Milliman Award Scholarships to Empower Africa's Next Generation of Climate Change Leaders

Retrieved on: 
Friday, February 23, 2024

The Africa Scholarship Programme aims to empower the next generation of leaders to drive solutions to Africa's climate threats.

Key Points: 
  • The Africa Scholarship Programme aims to empower the next generation of leaders to drive solutions to Africa's climate threats.
  • With limited resources, they are already driving change and making a real impact as young changemakers in their communities.
  • As ARC Ltd. CEO Lesley Ndlovu says: “The urgent need for Africa to develop leaders, including women leaders, well-versed in the complex challenges of climate change cannot be overstated.
  • These scholarships empower the next generation to gain the skills needed to drive climate resilience back home.”
    Milliman Inc.